These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1680293)

  • 21. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
    Coppola P
    Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of pharmacists and nurses toward interprofessional relations and decentralized pharmaceutical services.
    Thompson DF; Kaczmarek ER; Hutchinson RA
    Am J Hosp Pharm; 1988 Feb; 45(2):345-51. PubMed ID: 3364434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a pharmacist on the educational value of pharmaceutical industry film showings.
    Bayliff CD; Edington RD; Johnston LJ; Shaw PW; Bailey DG
    Can J Hosp Pharm; 1991 Dec; 44(6):283-7. PubMed ID: 10116487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effective clinical pharmacy services in a veterans administration drop-in clinic.
    Scrivens JJ; Magalian P; Crozier GA
    Am J Hosp Pharm; 1983 Nov; 40(11):1952-3. PubMed ID: 6418002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicians' attitudes toward drug-use evaluation interventions.
    Pierson JF; Alexander MR; Kirking DM; Solomon DK
    Am J Hosp Pharm; 1990 Feb; 47(2):388-90. PubMed ID: 2309734
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    Bremberg ER; Hising C; Nylén U; Ehrsson H; Eksborg S
    J Oncol Pharm Pract; 2006 Jun; 12(2):75-81. PubMed ID: 16984745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focus and impact of pharmacists' interventions.
    Strong DK; Tsang GW
    Can J Hosp Pharm; 1993 Jun; 46(3):101-8. PubMed ID: 10126864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing.
    Stewart DC; George J; Diack HL; Bond CM; McCaig DJ; Cunningham IS; Munro K; Pfleger D
    Ann Pharmacother; 2009 Jun; 43(6):1115-21. PubMed ID: 19417108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a fax document for transfer of medication information to family physicians and community pharmacists caring for hemodialysis outpatients.
    Riley KD; Wazny LD
    CANNT J; 2006; 16(1):24-8. PubMed ID: 16615703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacy-initiated introduction of patient-controlled analgesia to a 400-bed community hospital.
    McKenna TR; Branigan TA; Sorocki AH
    Am J Hosp Pharm; 1989 Feb; 46(2):291-4. PubMed ID: 2712047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacist empowerment: taking practice guidelines to the next level (Part 2).
    Puckett W; Egle L; Galt M
    Hosp Formul; 1994 Nov; 29(11):767-72. PubMed ID: 10138573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a cancer chemotherapy prescription form on prescription completeness.
    Thorn DB; Sexton MG; Lemay AP; Sarigianis JS; Melita DD; Gustafson NJ
    Am J Hosp Pharm; 1989 Sep; 46(9):1802-6. PubMed ID: 2801713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alberta Euthanasia Survey: 3-year follow-up.
    Verhoef MJ; Kinsella TD
    CMAJ; 1996 Oct; 155(7):885-90. PubMed ID: 8837535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists.
    Haxby DG; Weart CW; Goodman BW
    Am J Hosp Pharm; 1988 Apr; 45(4):824-7. PubMed ID: 3376965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.